CSPIA
TMO icon

Cary Street Partners Investment Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412K Buy
822
+53
+7% +$25.4K 0.08% 232
2026
Q1 		$378K Sell
769
-6
-0.8% -$3.26K 0.1% 232
2025
Q4 		$449K Buy
775
+122
+19% +$69K 0.12% 178
2025
Q3 		$317K Buy
653
+102
+19% +$47.5K 0.13% 173
2025
Q2 		$223K Sell
551
-203
-27% -$84.9K 0.11% 211
2025
Q1 		$375K Buy
754
+2
+0.3% +$1.08K 0.22% 117
2024
Q4 		$391K Sell
752
-31,514
-98% -$17.3M 0.26% 101
2024
Q3 		$20M Buy
32,266
+1,538
+5% +$910K 0.74% 29
2024
Q2 		$17M Buy
30,728
+562
+2% +$322K 0.69% 32
2024
Q1 		$17.5M Buy
30,166
+412
+1% +$231K 0.74% 27
2023
Q4 		$15.8M Buy
29,754
+1,886
+7% +$913K 0.75% 29
2023
Q3 		$14.1M Buy
27,868
+3,886
+16% +$2.07M 0.76% 25
2023
Q2 		$12.5M Sell
23,982
-654
-3% -$353K 0.8% 24
2023
Q1 		$14.2M Sell
24,636
-6
-0% -$3.38K 1.02% 16
2022
Q4 		$13.6M Sell
24,642
-353
-1% -$187K 1% 17
2022
Q3 		$12.7M Buy
24,995
+1,711
+7% +$958K 1.04% 21
2022
Q2 		$12.7M Buy
23,284
+14,671
+170% +$8.08M 1.07% 19
2022
Q1 		$5.09M Sell
8,613
-53
-0.6% -$30.4K 1.4% 13
2021
Q4 		$5.78M Buy
8,666
+107
+1% +$66.8K 1.6% 11
2021
Q3 		$4.89M Sell
8,559
-531
-6% -$291K 1.6% 12
2021
Q2 		$4.58M Buy
9,090
+4,656
+105% +$2.2M 1.48% 12
2021
Q1 		$2.02M Sell
4,434
-1,093
-20% -$522K 0.83% 27
2020
Q4 		$2.57M Sell
5,527
-3,308
-37% -$1.55M 0.5% 48
2020
Q3 		$3.9M Buy
+8,835
New +$3.65M 0.83% 33

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Cary Street Partners Investment Advisory's TMO Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its Thermo Fisher Scientific (TMO) stake by 6.9% in Q2 2026, buying an estimated $25.4K and bringing the position to 822 shares worth $412K. The position accounts for 0.08% of the portfolio, ranked #232.

Cary Street Partners Investment Advisory first reported a position in TMO in Q3 2020 and has held it in 24 quarters since. The position peaked at $20M in Q3 2024. 1,901 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cary Street Partners Investment Advisory held 822 shares of Thermo Fisher Scientific worth $412K as of Q2 2026.
  • Cary Street Partners Investment Advisory bought 53 Thermo Fisher Scientific shares in Q2 2026, an estimated $25.4K.
  • Thermo Fisher Scientific made up 0.08% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #232 holding.
  • Cary Street Partners Investment Advisory first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 24 quarters since.
  • Cary Street Partners Investment Advisory's Thermo Fisher Scientific position peaked at $20M in Q3 2024.
  • 1,901 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.